Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lise Tarnow

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
Danish Medical Bulletin|March 16, 2002
Diabetic nephropathy. Pathogenetic aspects and cardiovascular risk factorsLise Tarnow
Journal of Diabetes and Its Complications|March 31, 2012
Prevalence of gastroparesis-related symptoms in an unselected cohort of patients with Type 1 diabetesKristoffer Kofod-Andersen, Lise Tarnow
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Comparison of Multidrug Use in the General Population and among Persons with Diabetes in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing GuidelinesNiels Westergaard, Lise Tarnow, Charlotte Vermehren
Metabolites|February 13, 2021
Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug TherapyNiels Westergaard, Lise Tarnow, Charlotte Vermehren
European Endocrinology|October 24, 2018
Sleeping Beauty or the Beast? - Metabolic Syndrome from an Obstructive Sleep Apnoea PerspectiveLise Tarnow, Brigitte Klinkenbijl, Holger Woehrle
Scandinavian Journal of Clinical and Laboratory Investigation|September 29, 2018
Intermittent vacuum treatment with VacuMed does not improve peripheral artery disease or walking capacity in patients with intermittent claudicationPia Afzelius, Stig Molsted, Lise Tarnow
Current Hypertension Reports|September 3, 2004
Remission and regression of diabetic nephropathyPeter Hovind, Lise Tarnow, Hans-Henrik Parving
Ugeskrift for Laeger|June 16, 2009
[Genetics and hypertension]Christina Ellervik, Lise Tarnow, Erling Bjerregaard Pedersen
Molecular Genetics and Metabolism|February 28, 2009
The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetesAnna Möllsten, Maria Lajer, Anders Jorsal, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 23, 2005
Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathyLise Tarnow, Anne Sofie Astrup, Hans-Henrik Parving
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
Danish Medical Bulletin|March 16, 2002
Diabetic nephropathy. Pathogenetic aspects and cardiovascular risk factorsLise Tarnow
Journal of Diabetes and Its Complications|March 31, 2012
Prevalence of gastroparesis-related symptoms in an unselected cohort of patients with Type 1 diabetesKristoffer Kofod-Andersen, Lise Tarnow
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Comparison of Multidrug Use in the General Population and among Persons with Diabetes in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing GuidelinesNiels Westergaard, Lise Tarnow, Charlotte Vermehren
Metabolites|February 13, 2021
Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug TherapyNiels Westergaard, Lise Tarnow, Charlotte Vermehren
European Endocrinology|October 24, 2018
Sleeping Beauty or the Beast? - Metabolic Syndrome from an Obstructive Sleep Apnoea PerspectiveLise Tarnow, Brigitte Klinkenbijl, Holger Woehrle
Scandinavian Journal of Clinical and Laboratory Investigation|September 29, 2018
Intermittent vacuum treatment with VacuMed does not improve peripheral artery disease or walking capacity in patients with intermittent claudicationPia Afzelius, Stig Molsted, Lise Tarnow
Current Hypertension Reports|September 3, 2004
Remission and regression of diabetic nephropathyPeter Hovind, Lise Tarnow, Hans-Henrik Parving
Ugeskrift for Laeger|June 16, 2009
[Genetics and hypertension]Christina Ellervik, Lise Tarnow, Erling Bjerregaard Pedersen
Molecular Genetics and Metabolism|February 28, 2009
The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetesAnna Möllsten, Maria Lajer, Anders Jorsal, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 23, 2005
Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathyLise Tarnow, Anne Sofie Astrup, Hans-Henrik Parving
Pageof 19